The expression of COL11A1, COL5A1 and COL6A2 is related to overall survival (OS) rate in patients with high-grade serous ovarian cancer, and their increased expression may also lead to the resistance of ovarian cancer cell lines (28). This evidence concerns the gene COL6A2 and ovarian cancer.